Can a Nurse-Led online tool help rheumatoid arthritis patients manage flares from home?

NCT ID NCT07525856

Not yet recruiting Symptom relief Sponsor: CHU de Quebec-Universite Laval Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study will test whether a nurse-led telehealth self-monitoring program is acceptable and practical for people with rheumatoid arthritis. 104 adults who recently had a flare or medication change will use a web platform to report symptoms monthly. A rheumatology nurse will review their reports and provide guidance. The study aims to see if this approach is convenient and helpful for patients and clinics.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Nurse-led telehealth remote self-monitoring via a web platform
What this could lead to: If successful, this approach could offer a convenient, nurse-supported way for rheumatoid arthritis patients to monitor their condition from home and get timely care.
What could go wrong: This is a small pilot study (104 participants) testing only acceptability and feasibility, not effectiveness. The results may not apply to all patients or clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RHEUMATOID ARTHRITIS (RA)

Contacts and locations

Locations

CHU de Quebec-Universite Laval

Québec, Quebec, G1V4G2, Canada
Centre de l'ostéporose et de rhumatologie de Québec

Québec, Quebec, G1V 2M1, Canada
Hopital Fleurimont et Hotel Dieu de Sherbrooke

Sherbrooke, Quebec, J1H 5H3, Canada
Hopital general de Montreal

Montreal, Quebec, H3H 1V6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.